Emerging drugs for acute lung injury.

about

Dexmedetomidine alleviates lipopolysaccharide-induced lung injury in Wistar rats.Differential Regulation of NF-κB and Nrf2 by Bojungikki-Tang Is Associated with Suppressing Lung Inflammation.Alternative and Natural Therapies for Acute Lung Injury and Acute Respiratory Distress Syndrome.

P2860

Q41280020-3933DED1-731C-4EE1-800A-0304D1017E84 Q52720181-90AA0D70-A12E-47DB-9080-949443B99689 Q55128734-D6FAC70D-7CBC-4717-84C8-862F5004AC6D

P2860

Emerging drugs for acute lung injury.

Item

http://www.wikidata.org/entity/Q38308143

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Emerging drugs for acute lung injury.

@en

type

Item

label

Emerging drugs for acute lung injury.

@en

prefLabel

Emerging drugs for acute lung injury.

@en

P1476

Emerging drugs for acute lung injury.

@en

P2093

Daniela Impellizzeri

http://www.w3.org/2001/XMLSchema#string

Emanuela Esposito

http://www.w3.org/2001/XMLSchema#string

Giuseppe Bruschetta

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of prone positioning during mechanical ventilation on mortality among patients with acute respiratory distress syndrome: a systematic review and meta-analysis

Bench-to-bedside review: beta2-Agonists and the acute respiratory distress syndrome

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

Proteases and lung injury

Efficacy and safety of recombinant human activated protein C for severe sepsis

The acute respiratory distress syndrome

Intensive insulin therapy in critically ill patients

Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores.

Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury

A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury

P304

75-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.2015.1000299

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salvatore Cuzzocrea

P577

2015-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25560706

http://www.w3.org/2001/XMLSchema#string

Emerging drugs for acute lung injury.

about

P2860

P2860

Emerging drugs for acute lung injury.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698